Edward K. Kasper

32.6k total citations · 3 hit papers
100 papers, 8.2k citations indexed

About

Edward K. Kasper is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Physiology. According to data from OpenAlex, Edward K. Kasper has authored 100 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Cardiology and Cardiovascular Medicine, 44 papers in Surgery and 15 papers in Physiology. Recurrent topics in Edward K. Kasper's work include Viral Infections and Immunology Research (27 papers), Transplantation: Methods and Outcomes (19 papers) and Sarcoidosis and Beryllium Toxicity Research (14 papers). Edward K. Kasper is often cited by papers focused on Viral Infections and Immunology Research (27 papers), Transplantation: Methods and Outcomes (19 papers) and Sarcoidosis and Beryllium Toxicity Research (14 papers). Edward K. Kasper collaborates with scholars based in United States, Australia and Netherlands. Edward K. Kasper's co-authors include Kenneth L. Baughman, Joshua M. Hare, Ralph H. Hruban, G. Michael Felker, Hugh Calkins, David L. Howard, Grover M. Hutchins, Richard E. Thompson, Joshua A. Beckman and Judy R. Kersten and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Edward K. Kasper

97 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy

2000 1.2k citations G. Michael Felker, Joshua M. Hare et al. profile →
Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis

2000 537 citations John Boehmer, Ralph H. Hruban et al. profile →
Beat-to-Beat QT Interval Variability

1997 502 citations Edward K. Kasper, Kenneth L. Baughman et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward K. Kasper United States	41	6.2k	2.9k	1.3k	871	722	100	8.2k
Angelo Branzi Italy	47	6.2k 1.0×	2.4k 0.8×	2.3k 1.7×	1.6k 1.8×	867 1.2×	307	9.1k
James C. Fang United States	47	5.0k 0.8×	2.1k 0.7×	1.2k 0.9×	643 0.7×	500 0.7×	174	7.5k
Robert M. Mentzer United States	51	3.2k 0.5×	3.4k 1.2×	1.2k 0.9×	1.5k 1.7×	468 0.6×	180	9.3k
G. William Dec United States	39	6.1k 1.0×	1.7k 0.6×	959 0.7×	1.8k 2.1×	565 0.8×	93	8.4k
Domingo A. Pascual‐Figal Spain	46	4.2k 0.7×	1.8k 0.6×	739 0.6×	865 1.0×	252 0.3×	304	7.3k
Andrew A. House Canada	36	2.4k 0.4×	1.3k 0.5×	1.5k 1.2×	544 0.6×	412 0.6×	166	7.0k
Svein Simonsen Norway	42	2.9k 0.5×	1.9k 0.7×	699 0.5×	897 1.0×	493 0.7×	175	6.1k
Paul Mohaçsi Switzerland	37	5.3k 0.9×	3.6k 1.3×	986 0.7×	667 0.8×	288 0.4×	150	8.9k
Anders Jeppsson Sweden	46	4.0k 0.7×	3.1k 1.1×	1.3k 1.0×	710 0.8×	513 0.7×	286	7.8k
Monica Colvin United States	40	7.1k 1.2×	4.2k 1.5×	1.2k 0.9×	677 0.8×	430 0.6×	118	11.2k

Countries citing papers authored by Edward K. Kasper

Since Specialization

Citations

This map shows the geographic impact of Edward K. Kasper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward K. Kasper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward K. Kasper more than expected).

Fields of papers citing papers by Edward K. Kasper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward K. Kasper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward K. Kasper. The network helps show where Edward K. Kasper may publish in the future.

Co-authorship network of co-authors of Edward K. Kasper

This figure shows the co-authorship network connecting the top 25 collaborators of Edward K. Kasper. A scholar is included among the top collaborators of Edward K. Kasper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward K. Kasper. Edward K. Kasper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gasperetti, Alessio, Edward K. Kasper, Lili A. Barouch, et al.. (2024). Eighteen‐Month Real‐World Experience Using Mavacamten for Treatment of Obstructive Hypertrophic Cardiomyopathy in a Racially Diverse Population. Journal of the American Heart Association. 13(15). e034069–e034069. 14 indexed citations

Pavlovic, Noelle, Jan M. Griffin, David R. Okada, et al.. (2022). Cardiac sarcoidosis outcome differences: A comparison of patients with de novo cardiac versus known extracardiac sarcoidosis at presentation. Respiratory Medicine. 198. 106864–106864. 17 indexed citations

Gilotra, Nisha A., Jan M. Griffin, Noelle Pavlovic, et al.. (2021). Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review. Journal of Cardiac Failure. 28(1). 113–132. 42 indexed citations

Tampakakis, Emmanouil, Benjamin W. Kelemen, John Rickard, et al.. (2014). Abstract 16651: Right Ventricular Effective Arterial Elastance is a Novel Predictor of Mortality in Pulmonary Hypertension Due to Left Heart Disease. Circulation. 130. 3 indexed citations

Silber, Harry A., Jeffrey C. Trost, Peter V. Johnston, et al.. (2012). Finger photoplethysmography during the Valsalva maneuver reflects left ventricular filling pressure. American Journal of Physiology-Heart and Circulatory Physiology. 302(10). H2043–H2047. 14 indexed citations

Krum, Henry, Andrew Forbes, Julie Yallop, et al.. (2012). Telephone Support to Rural and Remote Patients with Heart Failure: The Chronic Heart Failure Assessment by Telephone (CHAT) study. Cardiovascular Therapeutics. 31(4). 230–237. 48 indexed citations

Schlendorf, Kelly & Edward K. Kasper. (2011). Use of Novel and Conventional Biomarkers for Management of Patients With Heart Failure. Current Treatment Options in Cardiovascular Medicine. 13(6). 475–488. 4 indexed citations

Fleischmann, Kirsten E., Joshua A. Beckman, Christopher E. Buller, et al.. (2009). 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade. Journal of the American College of Cardiology. 54(22). 2102–2128. 65 indexed citations

Fleisher, Lee A., Joshua A. Beckman, Kenneth A. Brown, et al.. (2007). ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary. Journal of the American College of Cardiology. 50(17). 1707–1732. 324 indexed citations

10.

Rodríguez, E. René, Carmela D. Tan, Andrea A. Zachary, et al.. (2005). Antibody‐Mediated Rejection in Human Cardiac Allografts: Evaluation of Immunoglobulins and Complement Activation Products C4d and C3d as Markers. American Journal of Transplantation. 5(11). 2778–2785. 122 indexed citations

11.

Ardehali, Hossein, David L. Howard, A. Hariri, et al.. (2005). A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. American Heart Journal. 150(3). 459–463. 123 indexed citations

12.

Chang, Patricia P., J. Craig Longenecker, Nae‐Yuh Wang, et al.. (2005). Mild vs Severe Pulmonary Hypertension Before Heart Transplantation: Different Effects on Posttransplantation Pulmonary Hypertension and Mortality. The Journal of Heart and Lung Transplantation. 24(8). 998–1007. 63 indexed citations

13.

Rahman, J., Emelie F. Helou, Richard E. Thompson, et al.. (2004). Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. Journal of the American College of Cardiology. 43(3). 410–415. 213 indexed citations

14.

Bomma, Chandra, Julie Rutberg, Harikrishna Tandri, et al.. (2004). Misdiagnosis of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Journal of Cardiovascular Electrophysiology. 15(3). 300–306. 126 indexed citations

15.

Felker, G. Michael, John Boehmer, Ralph H. Hruban, et al.. (2000). Echocardiographic findings in fulminant and acute myocarditis. Journal of the American College of Cardiology. 36(1). 227–232. 266 indexed citations

16.

Kass, David A., et al.. (1996). Dose Dependence of Chronic Positive Inotropic Effect of Vesnarinone in Patients With Congestive Heart Failure Due to Idiopathic or Ischemic Cardiomyopathy. The American Journal of Cardiology. 78(6). 652–656. 12 indexed citations

17.

Kasper, Edward K., Willem R.P. Agema, Grover M. Hutchins, et al.. (1994). The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients. Journal of the American College of Cardiology. 23(3). 586–590. 209 indexed citations

18.

Gaudin, Paul B., Barry K. Rayburn, Grover M. Hutchins, et al.. (1994). Peritransplant Injury to the Myocardium Associated with the Development of Accelerated Arteriosclerosis in Heart Transplant Recipients. The American Journal of Surgical Pathology. 18(4). 338–346. 70 indexed citations

19.

Herskowitz, Ahvie, et al.. (1993). Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy. The American Journal of Cardiology. 71(11). 982–986. 52 indexed citations

20.

Kasper, Edward K., et al.. (1992). Cardiomyopathy of obesity: A clinicopathologic evaluation of 43 obese patients with heart failure. The American Journal of Cardiology. 70(9). 921–924. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact